Appleton Partners’s QuidelOrtho QDEL Stock Holding History

Appleton Partners’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,775	Closed	-$375K	–	315
2021 Q4	$375K	Hold	2,775	–	–	0.03%	240
2021 Q3	$392K	Hold	2,775	–	–	0.03%	220
2021 Q2	$356K	Buy	+2,775	New	+$327K	0.03%	229
2021 Q1	–	Sell	-1,500	Closed	-$269K	–	283
2020 Q4	$269K	Hold	1,500	–	–	0.03%	239
2020 Q3	$329K	Hold	1,500	–	–	0.04%	214
2020 Q2	$336K	Buy	+1,500	New	+$235K	0.04%	206

Other funds holding QDEL

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Appleton Partners's QDEL Position: Q1 2022 in Review

Appleton Partners sold out of QuidelOrtho (QDEL) in Q1 2022, closing a stake of 2,775 shares — an estimated $375K sold.

Appleton Partners first reported a position in QDEL in Q2 2020 and held it in 6 quarters. The position peaked at $392K in Q3 2021. 354 funds tracked by Wall St. Rank hold QDEL as of Q1 2022.

Appleton Partners reported no remaining QuidelOrtho position as of Q1 2022 after selling out during the quarter.
Appleton Partners sold 2,775 QuidelOrtho shares in Q1 2022, an estimated $375K.
Appleton Partners first reported a position in QuidelOrtho in Q2 2020 and held it in 6 quarters.
Appleton Partners's QuidelOrtho position peaked at $392K in Q3 2021.
354 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2022.

Based on Appleton Partners's 13F filing for Q1 2022, filed 5 Apr 2022.